Jump to content

Recommended Posts

Posted (edited)

A couple of notes:

1) This does not mean Teva is going to sell this in the USA any time soon... Some Truvada patents are still standing until 2021. FDA has approved many other HIV generics for PEPFAR

2) In the case they do sell them, price may be lower, but not much lower. Let's say $750. Half of Truvada. This may actually be AWFUL news for patients. Why? Because at $700ish, the generic will NOT have copay assistance, insurance companies will force you to use the generic, and patients will have to pay the cost of copays and deductibles 100%. With many plans these days have $1000ish deductibles the price for PrEP may go up significantly for people at checkout.

 

POZ.com has a nice writeup about the nuances of all this:

https://www.poz.com/article/fda-approves-generic-truvada

Edited by rawfuckr
Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use, Privacy Policy, and Guidelines. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.